Pharma IQ | 07/11/2010
Dr. Dave Miller, Senior Principal Scientist at Hoffmann La Roche, shares his views on how to optimise amorphous form selection, techniques to enhance amorphous drug performance and the best strategies to stabilise amorphous forms. He also offers his perspective on how best to capitalise on the commercial potential of amorphous forms and on what he thinks the future holds for development in this field. Haven’t got the technology to listen to the podcast? Download the the transcript here Impl...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More